Every recall we track for RISING PHARMACEUTICALS — 3 in all — plus the complaints and injury reports the public filed about them.
Rising Pharmaceuticals recalls 100-count Warfarin Sodium tablets (NDC 57237-119-01) due to impurities that could cause serious injury. Affected batches expire April 2023.
Rising Pharmaceuticals recalls 2.5 mg chewable methylphenidate tablets due to size variation in some tablets. This may affect safety and requires verification of product details.
Rising Pharmaceuticals recalls 25mg Meclizine HCl tablets with incorrect labeling instructions. Consumers should check product details and contact the company for guidance.
